Delivery Order SPE2DB22D1106-SPE2DB24FEYN9
Award Date
6/25/24
Potential Completion Date
6/26/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp's Corporate Office division. The $1,163.28 firm fixed-price delivery order is for the supply of 4,565,863,722 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The contract has an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,127,486 units of Atovaquone-Proguanil 250-100 100S, a pharmaceutical product, with a ceiling value of $13,789.79. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a final completion date of July 15, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,527.57 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S tablets. The contract has a total ceiling value of $1,834.36 and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $9,362.09 firm fixed price delivery order is for the supply of 4,563,969,392 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100S. The contract has a period of performance through March 15, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,402.66 firm fixed-price delivery order is for the supply of 4567240666 - ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2025 and was awarded on February 11, 2025. There was no set-aside designation used for this contract. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $13,690.26 for the procurement of ATOVAQUONE-PROGUANIL 250-100 100S, which are medical commodities used in healthcare. The contract has an ultimate completion date of April 3, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and there...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $12,285.94, is a delivery order for the supply of 4566997123 - ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement and has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,484.16, is a delivery order with a firm fixed price for the supply of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,272.60 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...